The reversal of drug resistance by two ‐dimensional titanium carbide Ti2C (2D Ti2C) in non‐small‐cell lung cancer via the depletion of intracellular antioxidant reserves
Conclusions2D Ti2C can reverse NSCLC chemoresistance both in vitro and in vivo, suggesting that it may potentially become a novel and effective means to treat chemoresistant NSCLC in the clinic.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Yue Zhu,
Baiyan Sui,
Xin Liu,
Jiao Sun Tags: ORIGINAL ARTICLE Source Type: research
More News: Antidoxidants | Cancer | Cancer & Oncology | Genetics | Lung Cancer | Multidrug Resistance | Non-Small Cell Lung Cancer | Study